HIV

Patients with HIV who switched to a treatment regimen that included tenofovir alafenamide (TAF) showed improvement in serum markers for hepatic steatosis (HS) among other benefits.

Youth without HIV had a longer life expectancy compared with youth with HIV when using a microsimulation modeling analysis.

Earlier antiretroviral therapy was found to be safe in regards to kidney health, with benefits of virologic suppression and immune reconstitution.

A high burden of HIV could indicate other underlying factors, such as limited access to health care resources and a risk of major depressive disorder.

Dr William R Short discusses how clinical trials and treatment by a doctor should change with new treatment available and needed.

Lower rates of cardiac surgery were found in patients living with HIV along with an increased risk of adverse events.

William R. Short, MD, MPH, of the University of Pennsylvania, discusses how a label update for bictegravir can help provide safe and effective HIV treatment for pregnant people.

Asian men who have sex with men (MSM) who recently immigrated to Australia were found to have lower uptake of pre-exposure prophylaxis (PrEP).

Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.

Men who have sex with men (MSM) who are HIV-negative reported interest in an injectable pre-exposure prophylaxis (PrEP) that lasted longer than the daily pill, regardless of cost or coverage.

A new study found that dentists were lacking in experience when it came to dental aspects of HIV infection.

HIV testing uptake was improved in immigrants after peer interventions with multiple strategies were implemented.

Pregnant women with HIV need targeted interventions and improved care to combat these adverse outcomes.

HIV testing, treatment, and intervention session delivery were among some areas that saw challenges in properly addressing youth experiencing homelessness during an HIV prevention trial.

A new study found that adults in custody of the Federal Bureau of Prisons have seen improved pre-exposure prophylaxis (PrEP) initiation and sustained treatment uptake for HIV.

Men who have sex with men (MSM) who primarily spoke Spanish and transgender women who spoke either English or Spanish had positive experiences with a mobile health (mHealth) intervention.

Older patients and patients of sub-Saharan African origin were at an increased risk of late presentation of advanced HIV.

Family medicine clerkships in medical school were found to have varying degrees of curriculum dedicated to pre-exposure prophylaxis (PrEP) based on the expertise or judgement of the faculty.

Although caregivers of patients living with HIV are significantly burdened with psychological and physical stresses, some described positive aspects of caregiving.

A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.

Men who have sex with men (MSM) were found to engage in more risk behaviors when self-testing for HIV.

Men who have sex with men who are living with HIV tend to have fewer depressive symptoms if they report better family functioning.

The US government’s program to send free COVID-19 tests is ending later this week; a new study found that Ozempic (semaglutide) may lower liver disease risks in people living with HIV; scientists use cells from amniotic fluid to grow miniature organs.

A nurse-led strategy for people living with HIV was able to reduce both blood pressure and cholesterol in a 12-month period.

The higher burden of comorbidities in patients with both HIV and pulmonary hypertension (PH) led to worse outcomes, including mortality.

Patients with HIV who have suppressed viral loads and pre-existing resistance will be able to use bictegravir with this FDA approval.

Different levels of risk for HIV exist in the different subtypes of intellectual and developmental disabilities.

Pregnant women who are living with HIV are underrepresented in studies on the efficacy of vaccines, leading to difficult policy decisions for this population.

Strategies used during the COVID-19 pandemic to ensure continuity of care in people living with HIV can be used as a paradigm of adaptability during unexpected crises.

Although rates of opioid use disorder (OUD) are higher than previous estimates, OUD was relatively stable or decreasing over time in patients with HIV.